-+ 0.00%
-+ 0.00%
-+ 0.00%

POLARYX THERAPEUTICS, - TO INITIATE SOTERIA PHASE 2 TRIAL IN Q4 2026

Reuters·08/25/2026 12:30:01

Please log in to view news